Comment on

• Oral arsenic and retinoic acid for non-high-risk acute promyelocytic leukemia.

  Zhu HH, Huang XJ. Zhu HH, et al. N Engl J Med. 2014 Dec 4;371(23):2239-41. doi: 10.1056/NEJMc1412035. N Engl J Med. 2014. PMID: 25470713 Clinical Trial. No abstract available.
• Outpatient oral treatment for acute promyelocytic leukemia.

  Lo-Coco F, Cicconi L. Lo-Coco F, et al. N Engl J Med. 2015 Feb 26;372(9):884-5. doi: 10.1056/NEJMc1500125. N Engl J Med. 2015. PMID: 25714181 No abstract available.